Novartis blockbuster Mayzent wins European nod for multiple sclerosis Medical Dialogues Bureau22 Jan 2020 11:25 AM IST The European marketing authorization makes Mayzent the first and only indicated oral treatment proven in SPMS patients with the active disease based...
EC approves Roche's Polivy combo in patients with previously treated aggressive lymphoma Medical Dialogues Bureau22 Jan 2020 11:01 AM ISTRoche announced that the European Commission has granted conditional marketing authorisation for Polivy® (polatuzumab vedotin), in combination with...
GSK Benlysta gets European nod for treatment of children with lupus Medical Dialogues Bureau4 Nov 2019 9:15 AM ISTNew Delhi: GlaxoSmithKline (GSK) plc recently announced that the European Commission has adopted a decision to extend to children five years and...
FDA grants priority review for Sanofi's dengue vaccine candidate Medical Dialogues Bureau4 Nov 2018 11:00 AM ISTThe vaccine, known as Dengvaxia in countries where it is approved, remains the only vaccine available for the prevention of dengue. The European...
GSK's severe pediatric asthma drug wins European panel thumbs-up Ruby Khatun Khatun30 July 2018 10:00 AM ISTGlaxoSmithKline (GSK) drug Nucala has won a key recommendation from a European Medicines Agency (EMA) panel for use in the treatment of children with...
Biocon, Mylan get European Commission approval to market biosimilar insulin glargine Ruby Khatun Khatun30 March 2018 10:30 AM ISTNew Delhi: Biotechnology major Biocon and Mylan said their co-developed biosimilar insulin glargine has received marketing authorization approval from...
Roche MS drug Ocrevus wins European panel backing Ruby Khatun Khatun13 Nov 2017 10:02 AM ISTZURICH: Swiss drugmaker Roche on Friday won a key European panel's recommendation for its multiple sclerosis drug Ocrevus, which is on track for...
